CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: UBE2V1 (ImmuneEditome ID:7335)

1. Gene summary of enriched editing regions for UBE2V1

check button Gene summary
Gene informationGene symbol

UBE2V1

Gene ID

7335

GeneSynonymsCIR1|CROC-1|CROC1|UBE2V|UEV-1|UEV1|UEV1A
GeneCytomap

20q13.13

GeneTypeprotein-coding
GeneDescriptionubiquitin-conjugating enzyme E2 variant 1|DNA-binding protein|TRAF6-regulated IKK activator 1 beta Uev1A
GeneModificationdate20230329
UniprotIDQ13404;D6RG00;G3V2F7
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr20:50084920-50085211:-ENST00000396059.6ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000432266.4ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000467839.4ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000472923.4ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000486653.4ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000490555.1ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000492371.5ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50084920-50085211:-ENST00000493090.4ENSG00000244687.10UBE2V1ncRNA_intronicAluSpchr20:50084920-50085211:-.alignment
chr20:50091083-50092314:-ENST00000396059.6ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000432266.4ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000467839.4ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000472923.4ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000486653.4ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000490555.1ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000492371.5ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment
chr20:50091083-50092314:-ENST00000493090.4ENSG00000244687.10UBE2V1ncRNA_intronicL1ME3G,AluSx,AluSz,AluSqchr20:50091083-50092314:-.alignment


Top

2. Tumor-specific enriched editing regions for UBE2V1


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot
ENSG00000244687.10,UBE2V1GBMEAG1.8009e-024.4262e-029.0854e-06image

Top

3. Enriched editing regions and immune related genes for UBE2V1


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for UBE2V1


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

5. Enriched editing regions and immune infiltration for UBE2V1


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
ENSG00000244687.10,UBE2V1BRCAEAGNeutrophils3.3327e-02-0.2849image
ENSG00000244687.10,UBE2V1COADEAGDendritic_cells_activated6.1140e-040.6373image
ENSG00000244687.10,UBE2V1ESCAEAGMast_cells_activated1.6319e-02-0.2095image
ENSG00000244687.10,UBE2V1KIRCEAGNK_cells_resting9.6184e-040.5480image
chr20:50091083-50092314:-LAMLEERNeutrophils7.1446e-030.3688image
ENSG00000244687.10,UBE2V1LUADEAGT_cells_CD81.4260e-020.3230image
ENSG00000244687.10,UBE2V1LUSCEAGMacrophages_M23.1926e-03-0.4347image
ENSG00000244687.10,UBE2V1OVEAGMacrophages_M08.1973e-03-0.2275image
chr20:50091083-50092314:-STADEERT_cells_CD4_memory_resting3.4990e-020.1717image
ENSG00000244687.10,UBE2V1STADEAGDendritic_cells_resting3.0222e-020.1452image
ENSG00000244687.10,UBE2V1THCAEAGMacrophages_M13.4168e-020.4016image


Top

6. Enriched editing regions and immune gene sets for UBE2V1


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000244687.10,UBE2V1BRCAGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG1.5973e-030.4122image
ENSG00000244687.10,UBE2V1COADGSVA_HALLMARK_SPERMATOGENESISEAG4.6320e-02-0.4021image
chr20:50084920-50085211:-LAMLGSVA_HALLMARK_KRAS_SIGNALING_DNEER3.1211e-03-0.5384image
ENSG00000244687.10,UBE2V1LGGGSVA_HALLMARK_APICAL_JUNCTIONEAG2.3108e-020.3274image
ENSG00000244687.10,UBE2V1LUADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG3.3125e-030.3826image
chr20:50091083-50092314:-OVGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER3.9370e-02-0.3449image
ENSG00000244687.10,UBE2V1OVGSVA_HALLMARK_PROTEIN_SECRETIONEAG9.3773e-040.2826image
chr20:50091083-50092314:-STADGSVA_HALLMARK_FATTY_ACID_METABOLISMEER2.4192e-030.2451image
ENSG00000244687.10,UBE2V1STADGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG1.2256e-020.1675image
ENSG00000244687.10,UBE2V1THCAGSVA_HALLMARK_BILE_ACID_METABOLISMEAG4.4650e-030.5211image


Top

7. Enriched editing regions and drugs for UBE2V1


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000244687.10,UBE2V1BRCAJNK.9LEAG1.0497e-030.4264image
ENSG00000244687.10,UBE2V1COADLFM.A13EAG1.7365e-03-0.5942image
ENSG00000244687.10,UBE2V1ESCAMidostaurinEAG2.7054e-020.1932image
chr20:50091083-50092314:-ESCAABT.888EER4.4968e-02-0.2143image
ENSG00000244687.10,UBE2V1KIRCGSK.650394EAG3.4121e-02-0.3699image
chr20:50091083-50092314:-LAMLMethotrexateEER4.1857e-02-0.2833image
ENSG00000244687.10,UBE2V1LAMLErlotinibEAG7.2428e-040.3946image
chr20:50084920-50085211:-LAMLGDC0941EER4.8598e-02-0.3760image
ENSG00000244687.10,UBE2V1LGGAICAREAG4.0253e-020.2972image
ENSG00000244687.10,UBE2V1LUADA.770041EAG1.1940e-02-0.3309image
ENSG00000244687.10,UBE2V1LUSCBortezomibEAG2.9880e-02-0.3277image
chr20:50091083-50092314:-OVATRAEER2.7147e-030.4850image
ENSG00000244687.10,UBE2V1OVLenalidomideEAG2.7517e-030.2577image
chr20:50091083-50092314:-STADEmbelinEER3.3097e-020.1735image
ENSG00000244687.10,UBE2V1STADBIRB.0796EAG3.4644e-030.1950image
ENSG00000244687.10,UBE2V1THCAABT.888EAG1.2912e-020.4638image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType